Alkem Laboratories Limited (NSE:ALKEM)
India · Delayed Price · Currency is INR 5,566.00
-73.50 (-1.30%)
At close: Mar 2, 2026
Alkem Laboratories Market Cap
Alkem Laboratories has a market cap or net worth of 674.29 billion as of March 2, 2026. Its market cap has increased by 9.48% in one year.
Market Cap
674.29B
Enterprise Value
650.97B
Revenue
142.53B
Ranking
n/a
PE Ratio
28.44
Stock Price
5,566.00
Market Cap Chart
Since December 23, 2015, Alkem Laboratories's market cap has increased from 165.20B to 674.29B, an increase of 308.16%. That is a compound annual growth rate of 14.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 674.29B | 2.42% |
| Dec 31, 2025 | 658.38B | -2.26% |
| Dec 31, 2024 | 673.62B | 8.29% |
| Dec 29, 2023 | 622.05B | 73.15% |
| Dec 30, 2022 | 359.26B | -17.09% |
| Dec 31, 2021 | 433.31B | 23.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.70T |
| Cipla | 1.09T |
| Mankind Pharma | 927.82B |
| Zydus Lifesciences | 927.45B |
| Aurobindo Pharma | 708.81B |
| Glenmark Pharmaceuticals | 602.98B |
| Laurus Labs | 580.78B |
| Ipca Laboratories | 387.89B |